ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
As part of an ongoing strategic review, Evonik has agreed to sell its Alzchem specialty chemicals unit to German private equity firm Bluo for an undisclosed sum. Alzchem has 1,300 employees and makes a range of ingredients used in crop protection chemicals, fertilizers, pigments, active pharmaceutical ingredients, and food additives. Last month, Evonik denied rumors that it was planning to sell its real estate and energy businesses to focus on chemicals.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter